Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational study
- 19 August 2009
- journal article
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 15 (9) , 1037-1042
- https://doi.org/10.1177/1352458509106543
Abstract
BackgroundKeywords
This publication has 17 references indexed in Scilit:
- Statistical methods for estimating the probability of spontaneous abortion in observational studies—Analyzing pregnancies exposed to coumarin derivativesReproductive Toxicology, 2008
- Using observational cohort data for studying drug effects on pregnancy outcome—Methodological considerationsReproductive Toxicology, 2008
- Pregnancy in multiple sclerosis patients treated with immunomodulators prior to or during part of the pregnancy: a descriptive study in the Spanish populationMultiple Sclerosis Journal, 2007
- IM interferon β-1a delays definite multiple sclerosis 5 years after a first demyelinating eventNeurology, 2006
- Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosisNeurology, 2005
- Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post‐partum relapseBrain, 2004
- Phenotypic abnormalities: Terminology and classificationAmerican Journal of Medical Genetics Part A, 2003
- Cognitive impairment in probable multiple sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 2003
- Guidelines for case classification for the national birth defects prevention studyBirth Defects Research Part A: Clinical and Molecular Teratology, 2003
- Rate of Pregnancy-Related Relapse in Multiple SclerosisNew England Journal of Medicine, 1998